EXC
50
3
HD
50
-7
SHW
59
-2
BK
66
3
KMI
63
8
BA
45
3
MOS
29
7
EQR
67
2
EQT
25
6
ETR
52
6
HAL
46
5
FLR
38
2
PYPL
37
-4
BAC
47
5
CHK
12
9
PX
62
14
IVZ
48
5
WFC
61
3
MUR
43
17
DHI
60
12
EXC
50
3
HD
50
-7
SHW
59
-2
BK
66
3
KMI
63
8
BA
45
3
MOS
29
7
EQR
67
2
EQT
25
6
ETR
52
6
HAL
46
5
FLR
38
2
PYPL
37
-4
BAC
47
5
CHK
12
9
PX
62
14
IVZ
48
5
WFC
61
3
MUR
43
17
DHI
60
12
Financhill
Back

RTX Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
47

RTX
RTX

Last Price:
101.54
Seasonality Move:
-0.45%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
47
RTX (RTX) is a Sell

Is RTX a Buy, Sell or Hold?

  • The current RTX [RTX] share price is $101.96. The Score for RTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RTX Stock Price Chart

What is RTX's stock price today?

  • The RTX share price today is $101.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RTX is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

RTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 35.45 Sell
Chaikin Money Flow: -9190505 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.39 - 107.47) Sell
Bollinger Bands (100): (92.5 - 105.06) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

RTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.74 Sell
20-day SMA: 106.09 Sell
50-day SMA: 104.2 Sell
200-day SMA: 89.46 Buy
8-day EMA: 104.7 Sell
20-day EMA: 105.32 Sell
50-day EMA: 103.53 Sell
200-day EMA: 95.1 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

RTX Earnings Growth & RTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.12 per share, an increase this year of $0.38 per share, and an increase next year of $0.71 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

RTX Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):